The global Human Coagulation Factor VIII market is projected to reach US$ 15770 million by 2030 from an estimated US$ 10930 million in 2024, at a CAGR of 6.3% during 2024 and 2030.

Human Coagulation Factor VIII Market

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.

Global Human Coagulation Factor VIII key players include Baxter, Bayer, CSL, Pfizer, Biogen, etc. Global top five manufacturers hold a share about 80%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 30 percent. In terms of product, Recombinant Factor VIII is the largest segment, with a share about 65%. And in terms of application, the largest application is Hemophilia A, followed by Spontanous / Trauma, Surgical, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VIII.

The Human Coagulation Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Coagulation Factor VIII market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Coagulation Factor VIII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.

Market Segmentation

Scope of Human Coagulation Factor VIII Market Report

Report Metric	Details
Report Name	Human Coagulation Factor VIII Market
Accounted market size in 2024	an estimated US$ 10930 million
Forecasted market size in 2030	US$ 15770 million
CAGR	6.3%
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Recombinant Factor VIII Plasma-derived Factor VIII
Segment by Application	Hemophilia A Spontanous / Trauma Surgical Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk, Greencross, Kedrion, BPL, Hualan Bio, RAAS
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Coagulation Factor VIII in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Coagulation Factor VIII sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

How fast is Human Coagulation Factor VIII Market growing?

Ans: The Human Coagulation Factor VIII Market witnessing a CAGR of 6.3% during the forecast period 2024-2030.

What is the Human Coagulation Factor VIII Market size in 2030?

Ans: The Human Coagulation Factor VIII Market size in 2030 will be US$ 15770 million.

What is the market share of major companies in Human Coagulation Factor VIII Market?

Ans: Global top five manufacturers hold a share about 80%.

What is the Human Coagulation Factor VIII Market share by type?

Ans: In terms of product, Recombinant Factor VIII is the largest segment, with a share about 65%.

Who are the main players in the Human Coagulation Factor VIII Market report?

Ans: The main players in the Human Coagulation Factor VIII Market are Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk, Greencross, Kedrion, BPL, Hualan Bio, RAAS

What are the Application segmentation covered in the Human Coagulation Factor VIII Market report?

Ans: The Applications covered in the Human Coagulation Factor VIII Market report are Hemophilia A, Spontanous / Trauma, Surgical, Other

What are the Type segmentation covered in the Human Coagulation Factor VIII Market report?

Ans: The Types covered in the Human Coagulation Factor VIII Market report are Recombinant Factor VIII, Plasma-derived Factor VIII

1 Study Coverage

1.1 Human Coagulation Factor VIII Product Introduction

1.2 Market by Type

1.2.1 Global Human Coagulation Factor VIII Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 Recombinant Factor VIII

1.2.3 Plasma-derived Factor VIII

1.3 Market by Application

1.3.1 Global Human Coagulation Factor VIII Market Size Growth Rate by Application (2019 VS 2023 VS 2030)

1.3.2 Hemophilia A

1.3.3 Spontanous / Trauma

1.3.4 Surgical

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Human Coagulation Factor VIII Market Size Estimates and Forecasts

2.1.1 Global Human Coagulation Factor VIII Revenue 2019-2030

2.1.2 Global Human Coagulation Factor VIII Sales 2019-2030

2.2 Human Coagulation Factor VIII Market Size by Region: 2023 Versus 2030

2.3 Human Coagulation Factor VIII Sales by Region (2019-2030)

2.3.1 Global Human Coagulation Factor VIII Sales by Region: 2019-2024

2.3.2 Global Human Coagulation Factor VIII Sales Forecast by Region (2025-2030)

2.3.3 Global Human Coagulation Factor VIII Sales Market Share by Region (2019-2030)

2.4 Human Coagulation Factor VIII Market Estimates and Projections by Region (2025-2030)

2.4.1 Global Human Coagulation Factor VIII Revenue by Region: 2019-2024

2.4.2 Global Human Coagulation Factor VIII Revenue Forecast by Region (2025-2030)

2.4.3 Global Human Coagulation Factor VIII Revenue Market Share by Region (2019-2030)

3 Global Human Coagulation Factor VIII by Manufacturers

3.1 Global Top Human Coagulation Factor VIII Manufacturers by Sales

3.1.1 Global Human Coagulation Factor VIII Sales by Manufacturer (2019-2024)

3.1.2 Global Human Coagulation Factor VIII Sales Market Share by Manufacturer (2019-2024)

3.2 Global Top Human Coagulation Factor VIII Manufacturers by Revenue

3.2.1 Global Human Coagulation Factor VIII Revenue by Manufacturer (2019-2024)

3.2.2 Global Human Coagulation Factor VIII Revenue Share by Manufacturer (2019-2024)

3.3 Global Human Coagulation Factor VIII Price by Manufacturer (2019-2024)

3.4 Competitive Landscape

3.4.1 Key Human Coagulation Factor VIII Manufacturers Covered: Ranking by Revenue

3.4.2 Global Human Coagulation Factor VIII Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.4.3 Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global Human Coagulation Factor VIII Manufacturing Base Distribution, Product Type

3.5.1 Human Coagulation Factor VIII Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers Human Coagulation Factor VIII Product Type

3.5.3 Date of International Manufacturers Enter into Human Coagulation Factor VIII Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 Shire (Baxter)

4.1.1 Shire (Baxter) Company Information

4.1.2 Shire (Baxter) Description, Business Overview

4.1.3 Shire (Baxter) Human Coagulation Factor VIII Products Offered

4.1.4 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

4.1.5 Shire (Baxter) Human Coagulation Factor VIII Sales by Product in 2023

4.1.6 Shire (Baxter) Human Coagulation Factor VIII Sales by Application in 2023

4.1.7 Shire (Baxter) Human Coagulation Factor VIII Sales by Geographic Area in 2023

4.1.8 Shire (Baxter) Recent Developments

4.2 Bayer

4.2.1 Bayer Company Information

4.2.2 Bayer Description, Business Overview

4.2.3 Bayer Human Coagulation Factor VIII Products Offered

4.2.4 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

4.2.5 Bayer Human Coagulation Factor VIII Sales by Product in 2023

4.2.6 Bayer Human Coagulation Factor VIII Sales by Application in 2023

4.2.7 Bayer Human Coagulation Factor VIII Sales by Geographic Area in 2023

4.2.8 Bayer Recent Developments

4.3 CSL

4.3.1 CSL Company Information

4.3.2 CSL Description, Business Overview

4.3.3 CSL Human Coagulation Factor VIII Products Offered

4.3.4 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

4.3.5 CSL Human Coagulation Factor VIII Sales by Product in 2023

4.3.6 CSL Human Coagulation Factor VIII Sales by Application in 2023

4.3.7 CSL Human Coagulation Factor VIII Sales by Geographic Area in 2023

4.3.8 CSL Recent Developments

4.4 Pfizer

4.4.1 Pfizer Company Information

4.4.2 Pfizer Description, Business Overview

4.4.3 Pfizer Human Coagulation Factor VIII Products Offered

4.4.4 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

4.4.5 Pfizer Human Coagulation Factor VIII Sales by Product in 2023

4.4.6 Pfizer Human Coagulation Factor VIII Sales by Application in 2023

4.4.7 Pfizer Human Coagulation Factor VIII Sales by Geographic Area in 2023

4.4.8 Pfizer Recent Developments

4.5 Grifols

4.5.1 Grifols Company Information

4.5.2 Grifols Description, Business Overview

4.5.3 Grifols Human Coagulation Factor VIII Products Offered

4.5.4 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

4.5.5 Grifols Human Coagulation Factor VIII Sales by Product in 2023

4.5.6 Grifols Human Coagulation Factor VIII Sales by Application in 2023

4.5.7 Grifols Human Coagulation Factor VIII Sales by Geographic Area in 2023

4.5.8 Grifols Recent Developments

4.6 Biogen

4.6.1 Biogen Company Information

4.6.2 Biogen Description, Business Overview

4.6.3 Biogen Human Coagulation Factor VIII Products Offered

4.6.4 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

4.6.5 Biogen Human Coagulation Factor VIII Sales by Product in 2023

4.6.6 Biogen Human Coagulation Factor VIII Sales by Application in 2023

4.6.7 Biogen Human Coagulation Factor VIII Sales by Geographic Area in 2023

4.6.8 Biogen Recent Development

4.7 Octapharma

4.7.1 Octapharma Company Information

4.7.2 Octapharma Description, Business Overview

4.7.3 Octapharma Human Coagulation Factor VIII Products Offered

4.7.4 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

4.7.5 Octapharma Human Coagulation Factor VIII Sales by Product in 2023

4.7.6 Octapharma Human Coagulation Factor VIII Sales by Application in 2023

4.7.7 Octapharma Human Coagulation Factor VIII Sales by Geographic Area in 2023

4.7.8 Octapharma Recent Development

4.8 NovoNordisk

4.8.1 NovoNordisk Company Information

4.8.2 NovoNordisk Description, Business Overview

4.8.3 NovoNordisk Human Coagulation Factor VIII Products Offered

4.8.4 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

4.8.5 NovoNordisk Human Coagulation Factor VIII Sales by Product in 2023

4.8.6 NovoNordisk Human Coagulation Factor VIII Sales by Application in 2023

4.8.7 NovoNordisk Human Coagulation Factor VIII Sales by Geographic Area in 2023

4.8.8 NovoNordisk Recent Development

4.9 Greencross

4.9.1 Greencross Company Information

4.9.2 Greencross Description, Business Overview

4.9.3 Greencross Human Coagulation Factor VIII Products Offered

4.9.4 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

4.9.5 Greencross Human Coagulation Factor VIII Sales by Product in 2023

4.9.6 Greencross Human Coagulation Factor VIII Sales by Application in 2023

4.9.7 Greencross Human Coagulation Factor VIII Sales by Geographic Area in 2023

4.9.8 Greencross Recent Development

4.10 Kedrion

4.10.1 Kedrion Company Information

4.10.2 Kedrion Description, Business Overview

4.10.3 Kedrion Human Coagulation Factor VIII Products Offered

4.10.4 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

4.10.5 Kedrion Human Coagulation Factor VIII Sales by Product in 2023

4.10.6 Kedrion Human Coagulation Factor VIII Sales by Application in 2023

4.10.7 Kedrion Human Coagulation Factor VIII Sales by Geographic Area in 2023

4.10.8 Kedrion Recent Development

4.11 BPL

4.11.1 BPL Company Information

4.11.2 BPL Description, Business Overview

4.11.3 BPL Human Coagulation Factor VIII Products Offered

4.11.4 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

4.11.5 BPL Human Coagulation Factor VIII Sales by Product in 2023

4.11.6 BPL Human Coagulation Factor VIII Sales by Application in 2023

4.11.7 BPL Human Coagulation Factor VIII Sales by Geographic Area in 2023

4.11.8 BPL Recent Development

4.12 Hualan Bio

4.12.1 Hualan Bio Company Information

4.12.2 Hualan Bio Description, Business Overview

4.12.3 Hualan Bio Human Coagulation Factor VIII Products Offered

4.12.4 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

4.12.5 Hualan Bio Human Coagulation Factor VIII Sales by Product in 2023

4.12.6 Hualan Bio Human Coagulation Factor VIII Sales by Application in 2023

4.12.7 Hualan Bio Human Coagulation Factor VIII Sales by Geographic Area in 2023

4.12.8 Hualan Bio Recent Development

4.13 RAAS

4.13.1 RAAS Company Information

4.13.2 RAAS Description, Business Overview

4.13.3 RAAS Human Coagulation Factor VIII Products Offered

4.13.4 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

4.13.5 RAAS Human Coagulation Factor VIII Sales by Product in 2023

4.13.6 RAAS Human Coagulation Factor VIII Sales by Application in 2023

4.13.7 RAAS Human Coagulation Factor VIII Sales by Geographic Area in 2023

4.13.8 RAAS Recent Development

5 Breakdown Data by Type

5.1 Global Human Coagulation Factor VIII Sales by Type (2019-2030)

5.1.1 Global Human Coagulation Factor VIII Sales by Type (2019-2024)

5.1.2 Global Human Coagulation Factor VIII Sales Forecast by Type (2025-2030)

5.1.3 Global Human Coagulation Factor VIII Sales Market Share by Type (2019-2030)

5.2 Global Human Coagulation Factor VIII Revenue Forecast by Type (2019-2030)

5.2.1 Global Human Coagulation Factor VIII Revenue by Type (2019-2024)

5.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Type (2025-2030)

5.2.3 Global Human Coagulation Factor VIII Revenue Market Share by Type (2019-2030)

5.3 Human Coagulation Factor VIII Average Selling Price (ASP) by Type (2019-2030)

6 Breakdown Data by Application

6.1 Global Human Coagulation Factor VIII Sales by Application (2019-2030)

6.1.1 Global Human Coagulation Factor VIII Sales by Application (2019-2024)

6.1.2 Global Human Coagulation Factor VIII Sales Forecast by Application (2025-2030)

6.1.3 Global Human Coagulation Factor VIII Sales Market Share by Application (2019-2030)

6.2 Global Human Coagulation Factor VIII Revenue Forecast by Application (2019-2030)

6.2.1 Global Human Coagulation Factor VIII Revenue by Application (2019-2024)

6.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Application (2025-2030)

6.2.3 Global Human Coagulation Factor VIII Revenue Market Share by Application (2019-2030)

6.3 Human Coagulation Factor VIII Average Selling Price (ASP) by Application (2019-2030)

7 North America

7.1 North America Human Coagulation Factor VIII Market Size YoY Growth 2019-2030

7.2 North America Human Coagulation Factor VIII Market Facts & Figures by Country

7.2.1 North America Human Coagulation Factor VIII Sales by Country (2019-2030)

7.2.2 North America Human Coagulation Factor VIII Revenue by Country (2019-2030)

7.3 North America Human Coagulation Factor VIII Sales by Type (2019-2024)

7.4 North America Human Coagulation Factor VIII Sales by Application (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Human Coagulation Factor VIII Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Human Coagulation Factor VIII Market Facts & Figures by Region

8.2.1 Asia-Pacific Human Coagulation Factor VIII Sales by Region (2019-2030)

8.2.2 Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2019-2030)

8.3 Asia-Pacific Human Coagulation Factor VIII Sales by Type (2019-2024)

8.4 Asia-Pacific Human Coagulation Factor VIII Sales by Application (2019-2024)

9 Europe

9.1 Europe Human Coagulation Factor VIII Market Size YoY Growth 2019-2030

9.2 Europe Human Coagulation Factor VIII Market Facts & Figures by Country

9.2.1 Europe Human Coagulation Factor VIII Sales by Country (2019-2030)

9.2.2 Europe Human Coagulation Factor VIII Revenue by Country (2019-2030)

9.3 Europe Human Coagulation Factor VIII Sales by Type (2019-2024)

9.4 Europe Human Coagulation Factor VIII Sales by Application (2019-2024)

10 Latin America

10.1 Latin America Human Coagulation Factor VIII Market Size YoY Growth 2019-2030

10.2 Latin America Human Coagulation Factor VIII Market Facts & Figures by Country

10.2.1 Latin America Human Coagulation Factor VIII Sales by Country (2019-2030)

10.2.2 Latin America Human Coagulation Factor VIII Revenue by Country (2019-2030)

10.3 Latin America Human Coagulation Factor VIII Sales by Type (2019-2024)

10.4 Latin America Human Coagulation Factor VIII Sales by Application (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Human Coagulation Factor VIII Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Human Coagulation Factor VIII Market Facts & Figures by Country

11.2.1 Middle East and Africa Human Coagulation Factor VIII Sales by Country (2019-2030)

11.2.2 Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2019-2030)

11.3 Middle East and Africa Human Coagulation Factor VIII Sales by Type (2019-2024)

11.4 Middle East and Africa Human Coagulation Factor VIII Sales by Application (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Human Coagulation Factor VIII Supply Chain Analysis

12.2 Human Coagulation Factor VIII Key Raw Materials and Upstream Suppliers

12.3 Human Coagulation Factor VIII Clients Analysis

12.4 Human Coagulation Factor VIII Sales Channel and Sales Model Analysis

12.4.1 Human Coagulation Factor VIII Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Human Coagulation Factor VIII Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Human Coagulation Factor VIII Distributors

13 Market Dynamics

13.1 Human Coagulation Factor VIII Industry Trends

13.2 Human Coagulation Factor VIII Market Drivers

13.3 Human Coagulation Factor VIII Market Challenges

13.4 Human Coagulation Factor VIII Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Human Coagulation Factor VIII Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Manufacturers of Recombinant Factor VIII

Table 3. Major Manufacturers of Plasma-derived Factor VIII

Table 4. Global Human Coagulation Factor VIII Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Human Coagulation Factor VIII Market Size by Region (US$ Million): 2023 VS 2030

Table 6. Global Human Coagulation Factor VIII Sales by Region (2019-2024) & (K Bottles)

Table 7. Global Human Coagulation Factor VIII Sales Forecast by Region (2025-2030) & (K Bottles)

Table 8. Global Human Coagulation Factor VIII Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Human Coagulation Factor VIII Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 10. Global Human Coagulation Factor VIII Sales by Manufacturer (2019-2024) & (K Bottles)

Table 11. Global Human Coagulation Factor VIII Sales Share by Manufacturer (2019-2024)

Table 12. Human Coagulation Factor VIII Revenue by Manufacturer (2019-2024) & (US$ Million)

Table 13. Human Coagulation Factor VIII Revenue Share by Manufacturer (2019-2024)

Table 14. Key Manufacturers Human Coagulation Factor VIII Price (2019-2024) & (USD/Bottle)

Table 15. Ranking of Global Top Human Coagulation Factor VIII Manufacturers by Revenue (US$ Million) in 2023

Table 16. Global Human Coagulation Factor VIII Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 17. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2023)

Table 18. Human Coagulation Factor VIII Manufacturers Manufacturing Base Distribution and Headquarters

Table 19. Manufacturers Human Coagulation Factor VIII Product Type

Table 20. Date of International Manufacturers Enter into Human Coagulation Factor VIII Market

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Shire (Baxter) Company Information

Table 23. Shire (Baxter) Description and Business Overview

Table 24. Shire (Baxter) Human Coagulation Factor VIII Product

Table 25. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 26. Shire (Baxter) Sales Proportion of Human Coagulation Factor VIII by Product in 2023

Table 27. Shire (Baxter) Sales Proportion of Human Coagulation Factor VIII by Application in 2023

Table 28. Shire (Baxter) Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2023

Table 29. Shire (Baxter) Recent Development

Table 30. Bayer Company Information

Table 31. Bayer Description and Business Overview

Table 32. Bayer Human Coagulation Factor VIII Product

Table 33. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 34. Bayer Sales Proportion of Human Coagulation Factor VIII by Product in 2023

Table 35. Bayer Sales Proportion of Human Coagulation Factor VIII by Application in 2023

Table 36. Bayer Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2023

Table 37. Bayer Recent Development

Table 38. CSL Company Information

Table 39. CSL Description and Business Overview

Table 40. CSL Human Coagulation Factor VIII Product

Table 41. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 42. CSL Sales Proportion of Human Coagulation Factor VIII by Product in 2023

Table 43. CSL Sales Proportion of Human Coagulation Factor VIII by Application in 2023

Table 44. CSL Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2023

Table 45. CSL Recent Development

Table 46. Pfizer Company Information

Table 47. Pfizer Description and Business Overview

Table 48. Pfizer Human Coagulation Factor VIII Product

Table 49. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 50. Pfizer Sales Proportion of Human Coagulation Factor VIII by Product in 2023

Table 51. Pfizer Sales Proportion of Human Coagulation Factor VIII by Application in 2023

Table 52. Pfizer Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2023

Table 53. Pfizer Recent Development

Table 54. Grifols Company Information

Table 55. Grifols Description and Business Overview

Table 56. Grifols Human Coagulation Factor VIII Product

Table 57. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 58. Grifols Sales Proportion of Human Coagulation Factor VIII by Product in 2023

Table 59. Grifols Sales Proportion of Human Coagulation Factor VIII by Application in 2023

Table 60. Grifols Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2023

Table 61. Grifols Recent Development

Table 62. Biogen Company Information

Table 63. Biogen Description and Business Overview

Table 64. Biogen Human Coagulation Factor VIII Product

Table 65. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 66. Biogen Sales Proportion of Human Coagulation Factor VIII by Product in 2023

Table 67. Biogen Sales Proportion of Human Coagulation Factor VIII by Application in 2023

Table 68. Biogen Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2023

Table 69. Biogen Recent Development

Table 70. Octapharma Company Information

Table 71. Octapharma Description and Business Overview

Table 72. Octapharma Human Coagulation Factor VIII Product

Table 73. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 74. Octapharma Sales Proportion of Human Coagulation Factor VIII by Product in 2023

Table 75. Octapharma Sales Proportion of Human Coagulation Factor VIII by Application in 2023

Table 76. Octapharma Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2023

Table 77. Octapharma Recent Development

Table 78. NovoNordisk Company Information

Table 79. NovoNordisk Description and Business Overview

Table 80. NovoNordisk Human Coagulation Factor VIII Product

Table 81. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 82. NovoNordisk Sales Proportion of Human Coagulation Factor VIII by Product in 2023

Table 83. NovoNordisk Sales Proportion of Human Coagulation Factor VIII by Application in 2023

Table 84. NovoNordisk Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2023

Table 85. NovoNordisk Recent Development

Table 86. Greencross Company Information

Table 87. Greencross Description and Business Overview

Table 88. Greencross Human Coagulation Factor VIII Product

Table 89. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 90. Greencross Sales Proportion of Human Coagulation Factor VIII by Product in 2023

Table 91. Greencross Sales Proportion of Human Coagulation Factor VIII by Application in 2023

Table 92. Greencross Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2023

Table 93. Greencross Recent Development

Table 94. Kedrion Company Information

Table 95. Kedrion Description and Business Overview

Table 96. Kedrion Human Coagulation Factor VIII Product

Table 97. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 98. Kedrion Sales Proportion of Human Coagulation Factor VIII by Product in 2023

Table 99. Kedrion Sales Proportion of Human Coagulation Factor VIII by Application in 2023

Table 100. Kedrion Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2023

Table 101. Kedrion Recent Development

Table 102. BPL Company Information

Table 103. BPL Description and Business Overview

Table 104. BPL Human Coagulation Factor VIII Product

Table 105. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 106. BPL Sales Proportion of Human Coagulation Factor VIII by Product in 2023

Table 107. BPL Sales Proportion of Human Coagulation Factor VIII by Application in 2023

Table 108. BPL Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2023

Table 109. BPL Recent Development

Table 110. Hualan Bio Company Information

Table 111. Hualan Bio Description and Business Overview

Table 112. Hualan Bio Human Coagulation Factor VIII Product

Table 113. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 114. Hualan Bio Sales Proportion of Human Coagulation Factor VIII by Product in 2023

Table 115. Hualan Bio Sales Proportion of Human Coagulation Factor VIII by Application in 2023

Table 116. Hualan Bio Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2023

Table 117. Hualan Bio Recent Development

Table 118. RAAS Company Information

Table 119. RAAS Description and Business Overview

Table 120. RAAS Human Coagulation Factor VIII Product

Table 121. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 122. RAAS Sales Proportion of Human Coagulation Factor VIII by Product in 2023

Table 123. RAAS Sales Proportion of Human Coagulation Factor VIII by Application in 2023

Table 124. RAAS Sales Proportion of Human Coagulation Factor VIII by Geographic Area in 2023

Table 125. RAAS Recent Development

Table 126. Global Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)

Table 127. Global Human Coagulation Factor VIII Sales Forecast by Type (2025-2030) & (K Bottles)

Table 128. Global Human Coagulation Factor VIII Revenue by Type (2019-2024) & (US$ Million)

Table 129. Global Human Coagulation Factor VIII Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 130. Global Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)

Table 131. Global Human Coagulation Factor VIII Sales Forecast by Application (2025-2030) & (K Bottles)

Table 132. Global Human Coagulation Factor VIII Revenue by Application (2019-2024) & (US$ Million)

Table 133. Global Human Coagulation Factor VIII Revenue Forecast by Application (2025-2030) & (US$ Million)

Table 134. North America Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)

Table 135. North America Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)

Table 136. North America Human Coagulation Factor VIII Revenue by Country (2019-2024) & (US$ Million)

Table 137. North America Human Coagulation Factor VIII Revenue by Country (2025-2030) & (US$ Million)

Table 138. North America Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)

Table 139. North America Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)

Table 140. Asia-Pacific Human Coagulation Factor VIII Sales by Region (2019-2024) & (K Bottles)

Table 141. Asia-Pacific Human Coagulation Factor VIII Sales by Region (2025-2030) & (K Bottles)

Table 142. Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2019-2030) & (US$ Million)

Table 143. Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2025-2030) & (US$ Million)

Table 144. Asia-Pacific Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)

Table 145. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)

Table 146. Europe Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)

Table 147. Europe Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)

Table 148. Europe Human Coagulation Factor VIII Revenue by Country (2019-2024) & (US$ Million)

Table 149. Europe Human Coagulation Factor VIII Revenue by Country (2025-2030) & (US$ Million)

Table 150. Europe Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)

Table 151. Europe Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)

Table 152. Latin America Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)

Table 153. Latin America Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)

Table 154. Latin America Human Coagulation Factor VIII Revenue by Country (2019-2024) & (US$ Million)

Table 155. Latin America Human Coagulation Factor VIII Revenue by Country (2025-2030) & (US$ Million)

Table 156. Latin America Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)

Table 157. Latin America Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)

Table 158. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)

Table 159. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)

Table 160. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2019-2024) & (US$ Million)

Table 161. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2025-2030) & (US$ Million)

Table 162. Middle East and Africa Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)

Table 163. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)

Table 164. Human Coagulation Factor VIII Key Raw Materials, Industry Status and Trend

Table 165. Human Coagulation Factor VIII Key Raw Materials and Upstream Suppliers

Table 166. Human Coagulation Factor VIII Clients Status and Trend

Table 167. Human Coagulation Factor VIII Typical Clients

Table 168. Human Coagulation Factor VIII Distributors

Table 169. Human Coagulation Factor VIII Market Trends

Table 170. Human Coagulation Factor VIII Market Drivers

Table 171. Human Coagulation Factor VIII Market Challenges

Table 172. Human Coagulation Factor VIII Market Restraints

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

List of Figures

Figure 1. Human Coagulation Factor VIII Product Picture

Figure 2. Global Human Coagulation Factor VIII Sales Market Share by Type in 2023 & 2030

Figure 3. Recombinant Factor VIII Product Picture

Figure 4. Plasma-derived Factor VIII Product Picture

Figure 5. Global Human Coagulation Factor VIII Sales Market Share by Application in 2023 & 2030

Figure 6. Hemophilia A Examples

Figure 7. Spontanous / Trauma Examples

Figure 8. Surgical Examples

Figure 9. Other Examples

Figure 10. Human Coagulation Factor VIII Report Years Considered

Figure 11. Global Human Coagulation Factor VIII Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Human Coagulation Factor VIII Market Size 2019-2030 (US$ Million)

Figure 13. Global Human Coagulation Factor VIII Sales 2019-2030 (K Bottles)

Figure 14. Global Human Coagulation Factor VIII Sales Market Share Forecast by Region (2019-2030)

Figure 15. Global Human Coagulation Factor VIII Revenue Market Share by Region (2019-2030)

Figure 16. Global Human Coagulation Factor VIII Sales Share by Manufacturer in 2023

Figure 17. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 18. Global Human Coagulation Factor VIII Sales Market Share Forecast by Type (2019-2030)

Figure 19. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Type (2019-2030)

Figure 20. Human Coagulation Factor VIII Average Selling Price (ASP) by Type (2019-2024) & (USD/Bottle)

Figure 21. Global Human Coagulation Factor VIII Sales Market Share Forecast by Application (2019-2030)

Figure 22. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Application (2019-2030)

Figure 23. Human Coagulation Factor VIII Average Selling Price (ASP) by Application (2019-2024) & (USD/Bottle)

Figure 24. North America Human Coagulation Factor VIII Revenue 2019-2030 (US$ Million)

Figure 25. North America Human Coagulation Factor VIII Sales Market Share by Type (2019-2024)

Figure 26. North America Human Coagulation Factor VIII Sales Market Share by Application (2019-2024)

Figure 27. Asia-Pacific Human Coagulation Factor VIII Revenue 2019-2030 (US$ Million)

Figure 28. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Region (2019-2030)

Figure 29. Asia-Pacific Human Coagulation Factor VIII Revenue Market Share by Region (2019-2030)

Figure 30. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Type (2019-2024)

Figure 31. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Application (2019-2024)

Figure 32. Europe Human Coagulation Factor VIII Revenue Growth Rate 2019-2030 (US$ Million)

Figure 33. Europe Human Coagulation Factor VIII Sales Market Share by Country (2019-2030)

Figure 34. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2019-2030)

Figure 35. Europe Human Coagulation Factor VIII Sales Market Share by Type (2019-2024)

Figure 36. Europe Human Coagulation Factor VIII Sales Market Share by Application (2019-2024)

Figure 37. Latin America Human Coagulation Factor VIII Revenue Growth Rate 2019-2030 (US$ Million)

Figure 38. Latin America Human Coagulation Factor VIII Sales Market Share by Country (2019-2030)

Figure 39. Latin America Human Coagulation Factor VIII Revenue Market Share by Country (2019-2024)

Figure 40. Latin America Human Coagulation Factor VIII Sales Market Share by Type (2019-2024)

Figure 41. Latin America Human Coagulation Factor VIII Sales Market Share by Application (2019-2024)

Figure 42. Middle East and Africa Human Coagulation Factor VIII Revenue Growth Rate 2019-2030 (US$ Million)

Figure 43. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Country (2019-2030)

Figure 44. Middle East and Africa Human Coagulation Factor VIII Revenue Market Share by Country (2019-2030)

Figure 45. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Type (2019-2024)

Figure 46. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Application (2019-2024)

Figure 47. Human Coagulation Factor VIII Supply Chain (Upstream and Downstream Market)

Figure 48. Global Production Market Share of Human Coagulation Factor VIII Raw Materials by Region in 2023

Figure 49. Human Coagulation Factor VIII Distribution Channels

Figure 50. Global Human Coagulation Factor VIII Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 51. Global Human Coagulation Factor VIII Percentage 2019-2030: Online Sales VS Offline Sales

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions